Anti-allergy vaccine based on 'hygiene hypothesis'
...iss-based Cytos Biotechnology company to develop an anti-allergy drug that makes the immune system to focus on mycobacteria. This drug called CYT003 – qbg10 activates the immune system to attack potentially larger threats like mycobacteria, a group of bacteria found in soil and water that are come across r...